Data as of Sep 19
| +0.089 / +36.93%|
The 1 analysts offering 12-month price forecasts for Rock Creek Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +506.06% increase from the last price of 0.33.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.